ID
40395
Description
Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01500083
Link
https://clinicaltrials.gov/show/NCT01500083
Keywords
Versions (1)
- 4/18/20 4/18/20 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
April 18, 2020
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Indolent Non-Hodgkin's Lymphoma NCT01500083
Eligibility Indolent Non-Hodgkin's Lymphoma NCT01500083
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Study Subject Participation Status | Clinical Trial
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
- UMLS CUI [2]
- C0008976
Description
Patient Condition Quantity
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0030705
- UMLS CUI [1,2]
- C0348080
- UMLS CUI [1,3]
- C1265611
Description
Lymphoma transformation
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0024299
- UMLS CUI [1,2]
- C0040682
Description
Central nervous system lymphoma | Meningeal Lymphoma
Data type
boolean
Alias
- UMLS CUI [1]
- C0280803
- UMLS CUI [2]
- C2213017
Description
Cancer Other
Data type
boolean
Alias
- UMLS CUI [1]
- C1707251
Description
HIV
Data type
boolean
Alias
- UMLS CUI [1]
- C0019682
Description
Protocol Compliance Unlikely | Study Subject Participation Status Inappropriate
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0525058
- UMLS CUI [1,2]
- C0750558
- UMLS CUI [2,1]
- C2348568
- UMLS CUI [2,2]
- C1548788
Description
Eligibility Criteria Additional
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1516637
- UMLS CUI [1,2]
- C1524062
Similar models
Eligibility Indolent Non-Hodgkin's Lymphoma NCT01500083
- StudyEvent: Eligibility
C0004561 (UMLS CUI [1,2])
C0205336 (UMLS CUI [1,3])
C1334170 (UMLS CUI [2,1])
C0004561 (UMLS CUI [2,2])
C0205269 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C4047978 (UMLS CUI [3,2])
C0234227 (UMLS CUI [1,2])
C0332307 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0441800 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C1517677 (UMLS CUI [2,2])
C0024299 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0020532 (UMLS CUI [3,2])
C0015127 (UMLS CUI [3,3])
C0024299 (UMLS CUI [3,4])
C0023434 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,2])
C0332155 (UMLS CUI [1,3])
C1511118 (UMLS CUI [2])
C1514715 (UMLS CUI [3])
C0686904 (UMLS CUI [4,1])
C0087111 (UMLS CUI [4,2])
C0008976 (UMLS CUI [2])
C0348080 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0040682 (UMLS CUI [1,2])
C2213017 (UMLS CUI [2])
C0750558 (UMLS CUI [1,2])
C2348568 (UMLS CUI [2,1])
C1548788 (UMLS CUI [2,2])
C1524062 (UMLS CUI [1,2])